查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529719

发炎性肠道疾病疾病治疗的市场规模、份额和趋势分析报告：按类型、药物类别、给药途径、通路、地区、细分市场预测，2024-2030年

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

发炎性肠道疾病疾病治疗市场的成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球发炎性肠道疾病治疗市场规模将达277.3亿美元，2024年至2030年复合年增长率为3.8%。

预计该疾病盛行率的增加、人们对发炎性肠道疾病疾病认识的激增以及有利的监管环境将在预测期内推动发炎性肠道疾病治疗市场的发展。例如，2022年12月，辉瑞宣布美国FDA已接受其用于治疗严重溃疡性大肠炎患者的依曲莫德新药认证申请。指定发炎性肠道疾病治疗方法和核准新药的有利监管努力正在推动市场扩张。

市场相关人员和非营利组织之间加强合作，应对开发 IBD 治疗新疗法的各种挑战，预计将推动市场成长。例如，2022年10月，精准健康公司Verily与克隆氏症和结肠炎基金会扩大了策略伙伴关係，以加速溃疡性大肠炎和克隆氏症的研究。此外，欧洲克隆氏症和结肠炎组织已采取一些积极措施来改善发炎性肠道疾病疾病患者的照护。

最近核准用于治疗发炎性肠道疾病，如 filgotinib、 ozanimod、 Upadacitinib和 risankizumab，预计将在未来几年支持市场成长。此外，监管机构鼓励製造商开发针对罕见和危及生命的疾病的新治疗方法。例如，2020年12月，Thetis Pharmaceuticals的TP-317获得美国FDA授予的孤儿药资格，用于治疗小儿溃疡性大肠炎。这些有利的倡议预计将促进研发活动，开发 IBD 的新型治疗产品。

此外，用于治疗各种发炎疾病的生物相似药的需求和核准不断增长是市场的影响因素。例如，2022年12月，美国FDA核准Idacio作为第八个Adalimumab单抗生物相似药。新核准的生物相似药是一种不含柠檬酸盐的低浓度製剂，旨在治疗成人和 6 岁及以上儿童的多种发炎疾病，包括 CD。此外，2021年10月，美国FDA核准Ciltezo用于治疗中重度CD和UC。此外，越来越多地引入生物相似药预计将推动新兴经济体采用生物製药来治疗 IBD。

此外，政府机构正在努力促进生物相似药的安全使用。例如，2022 年 10 月，萨斯喀彻尔省政府推出了一项倡议，帮助居民获得更便宜、更高品质的治疗。同样，安大略省和魁北克省等加拿大省份正在扩大其生物相似倡议，以加速生物相似药候选药物的采用。

发炎性肠道疾病市场报告亮点

  • 由于生物製药作为治疗剂的盛行率不断增加和处方率较高，克隆氏症领域占据了最大的市场份额。
  • 由于用于治疗溃疡性大肠炎的生物製药的核准不断增加以及庞大的患者群体，溃疡性大肠炎市场预计将录得最快的增长率。
  • 由于 IBD 治疗的处方率较高以及消费者对 TNF 抑制剂的认识不断增强，TNF 抑制剂细分市场在 2023 年占据最大的市场占有率。
  • 从给药途径来看，注射剂细分市场将在 2023 年主导发炎性肠道疾病治疗市场，而口服细分市场预计将成长最快。
  • 2023年，由于住院率上升和有利的报销选择，医院药房部门成为最大的部门。
  • 由于市场参与企业增加投资以及该地区疾病盛行率上升，预计亚太地区在预测期内将呈现最快的成长速度。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章发炎性肠道疾病治疗市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 发炎性肠道疾病治疗市场分析工具
    • 波特的分析
    • PESTEL分析
  • 主要产品一览表及平均售价

第四章发炎性肠道疾病治疗市场：按类型估计和趋势分析

  • 细分仪表板
  • 发炎性肠道疾病治疗市场：2023 年和 2030 年按类型分類的变化分析
  • 克隆氏症
  • 溃疡性大肠炎

第五章发炎性肠道疾病治疗市场：按药物类别估计和趋势分析

  • 细分仪表板
  • 发炎性肠道疾病治疗市场：2023 年和 2030 年按药物类别的变化分析
  • 胺基水杨酸
  • 皮质类固醇
  • 肿瘤坏死因子抑制剂
  • IL抑制剂
  • 抗整合素
  • JAK抑制剂
  • 其他的

第六章发炎性肠道疾病治疗市场：依给药途径估计与趋势分析

  • 细分仪表板
  • 发炎性肠道疾病治疗市场：2023 年和 2030 年按给药途径的变化分析
  • 口服
  • 注射

第七章发炎性肠道疾病治疗市场：按分销管道估计和趋势分析

  • 细分仪表板
  • 发炎性肠道疾病治疗市场：2023 年和 2030 年按分销管道分類的变化分析
  • 医院药房
  • 零售药房
  • 网路药房

第八章发炎性肠道疾病疾病治疗市场：区域估计和趋势分析

  • 2023年及2030年发炎性肠道疾病治疗市场占有率（按地区）
  • 北美洲
    • 2018-2030年北美发炎性肠道疾病治疗市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030年欧洲发炎性肠道疾病治疗市场估计与预测
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区发炎性肠道疾病治疗市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 新加坡
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲发炎性肠道疾病治疗市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 2018-2030年中东和非洲发炎性肠道疾病治疗市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 2023 年企业市场占有率分析
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与协作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • AbbVie Inc.
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc.
    • Biogen
    • Novartis AG
    • Lilly
    • UCB SA
    • CELLTRION INC.
    • Merck &Co., Inc.
    • Johnson &Johnson Services, Inc
Product Code: GVR-3-68038-114-6

Inflammatory Bowel Disease Treatment Market Growth & Trends:

The global inflammatory bowel disease treatment market size is expected to reach USD 27.73 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of the disease, the surge in awareness about inflammatory bowel disease among people, and favorable regulatory scenarios are projected to drive the inflammatory bowel disease treatment market over the forecast period. For instance, in December 2022, Pfizer Inc. announced the U.S. FDA acceptance for review of an NDA for etrasimod for patients having severe ulcerative colitis. The favorable initiatives undertaken by regulatory authorities for treatment designations and approval of novel drugs for the management of inflammatory bowel disease are fueling market expansion.

The increasing collaboration of market players and non-profit organizations to counter various challenges in the development of novel therapeutics for IBD treatment is projected to propel market growth. For instance, in October 2022, Verily, a precision health company and the Crohn's & Colitis Foundation expanded their strategic collaboration to accelerate research in ulcerative colitis and Crohn's disease. In addition, the European Crohn's and Colitis Organization has taken several favorable steps to improve the care of patients living with inflammatory bowel disease.

Recently approved novel drugs such as filgotinib, ozanimod, upadacitinib, and risankizumab for the treatment of inflammatory bowel disease are expected to support market growth in the coming years. Moreover, the regulatory authorities are encouraging manufacturers to develop novel therapeutic approaches for rare and life-threatening diseases. For instance, in December 2020, Thetis Pharmaceuticals received an orphan drug designation for TP-317 from the U.S. FDA for pediatric ulcerative colitis. Such favorable initiatives are expected to boost the R&D activities to develop novel therapeutic products for IBD.

Furthermore, the rising demand & approvals for biosimilars for the treatment of various inflammatory conditions is a high-impact rendering factor for the market. For instance, in December 2022, the U.S. FDA approved Idacio as an eighth adalimumab biosimilar in the U.S. The newly approved biosimilar is a citrate-free low-concentration preparation intended for the treatment of several inflammatory conditions, including CD in adults and children aged 6 years or older. In addition, in October 2021, the U.S. FDA approved Cyltezo for the management of moderate to severe CD and UC. Moreover, the increasing introduction of biosimilars is expected to boost the adoption of biological products for the treatment of IBD in developing economies.

Moreover, government bodies are taking efforts to promote the uptake of biosimilars with their safe use. For instance, in October 2022, the government of Saskatchewan launched a biosimilar initiative to help its residents to access high-quality therapeutics at a lesser cost. Similarly, provinces like Ontario and Quebec in Canada are also expanding biosimilar initiatives to promote the uptake of biosimilar candidates.

Inflammatory Bowel Disease Market Report Highlights:

  • The Crohn's disease segment held the largest share owing to the increasing prevalence of the condition and the high prescription rate of biologics for the treatment of the disease
  • The ulcerative colitis segment is poised to register the fastest growth rate due to the rising approval of biologics for the treatment of ulcerative colitis and the high patient base
  • The TNF inhibitors segment accounted for the largest market share in 2023 owing to the high prescription rate for the treatment of IBD and rising consumer awareness about TNF inhibitors
  • Based on the route of administration, the injectable segment dominated the inflammatory bowel disease treatment market in 2023, whereas the oral segment is anticipated to be the fastest-growing segment
  • The hospital pharmacy segment was the largest in 2023, owing to higher hospitalization rates and favorable reimbursement coverage
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing disease prevalence in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Drug Class
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Inflammatory Bowel Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Robust product pipeline
      • 3.2.1.2. High prevalence of Crohn's disease and ulcerative colitis
      • 3.2.1.3. Increasing geriatric population
      • 3.2.1.4. Emergence of biosimilars
      • 3.2.1.5. Support of regulatory bodies for funding and designation
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Lack of early diagnosis
  • 3.3. Inflammatory Bowel Disease Treatment Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. List of Main Products & Average Selling Price

Chapter 4. Inflammatory Bowel Disease Treatment Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Inflammatory Bowel Disease Treatment Market: Type Movement Analysis, USD Billion, 2023 & 2030
  • 4.3. Crohn's Disease
    • 4.3.1. Crohn's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Ulcerative Colitis
    • 4.4.1. Ulcerative Colitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Inflammatory Bowel Disease Treatment Market: Drug Class Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Inflammatory Bowel Disease Treatment Market: Drug Class Movement Analysis, USD Billion, 2023 & 2030
  • 5.3. Aminosalicylates
    • 5.3.1. Aminosalicylates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Corticosteroids
    • 5.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. TNF Inhibitors
    • 5.5.1. TNF Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. IL Inhibitors
    • 5.6.1. IL Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Anti-integrin
    • 5.7.1. Anti-integrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. JAK Inhibitors
    • 5.8.1. JAK Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Inflammatory Bowel Disease Treatment Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Inflammatory Bowel Disease Treatment Market: Route of Administration Movement Analysis, USD Billion, 2023 & 2030
  • 6.3. Oral
    • 6.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Injectable
    • 6.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Inflammatory Bowel Disease Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Inflammatory Bowel Disease Treatment Market: Distribution Channel Movement Analysis, USD Billion, 2023 & 2030
  • 7.3. Hospital Pharmacy
    • 7.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Inflammatory Bowel Disease Treatment Market: Regional Estimates & Trend Analysis

  • 8.1. Inflammatory Bowel Disease Treatment Market Share, By Region, 2023 & 2030, USD Billion
  • 8.2. North America
    • 8.2.1. North America Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.2.2.3. Competitive Insights
      • 8.2.2.4. U.S. Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.2.3.3. Competitive Insights
      • 8.2.3.4. Canada Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.2.3. Competitive Insights
      • 8.3.2.4. Germany Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.3.3. Competitive Insights
      • 8.3.3.4. UK Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.4. Spain
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.4.3. Competitive Insights
      • 8.3.4.4. Spain Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.5.3. Competitive Insights
      • 8.3.5.4. France Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.6.3. Competitive Insights
      • 8.3.6.4. Italy Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.7.3. Competitive Insights
      • 8.3.7.4. Denmark Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.8.3. Competitive Insights
      • 8.3.8.4. Sweden Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.9.3. Competitive Insights
      • 8.3.9.4. Norway Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. Japan Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. China Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. India Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.5.3. Competitive Insights
      • 8.4.5.4. South Korea Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.6.3. Competitive Insights
      • 8.4.6.4. Australia Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.7. Singapore
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.7.3. Competitive Insights
      • 8.4.7.4. Singapore Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.8.3. Competitive Insights
      • 8.4.8.4. Thailand Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. Brazil Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Mexico Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. Argentina Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. South Africa Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. Saudi Arabia Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. UAE Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. Kuwait Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Strategy Mapping
    • 9.4.1. Expansion
    • 9.4.2. Mergers & Acquisition
    • 9.4.3. Partnerships & Collaborations
    • 9.4.4. New Product Launches
    • 9.4.5. Research And Development
  • 9.5. Company Profiles
    • 9.5.1. AbbVie Inc.
      • 9.5.1.1. Participant's Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Recent Developments
    • 9.5.2. Takeda Pharmaceutical Company Limited
      • 9.5.2.1. Participant's Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Recent Developments
    • 9.5.3. Pfizer Inc.
      • 9.5.3.1. Participant's Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Recent Developments
    • 9.5.4. Biogen
      • 9.5.4.1. Participant's Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Recent Developments
    • 9.5.5. Novartis AG
      • 9.5.5.1. Participant's Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Recent Developments
    • 9.5.6. Lilly
      • 9.5.6.1. Participant's Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Recent Developments
    • 9.5.7. UCB S.A.
      • 9.5.7.1. Participant's Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Recent Developments
    • 9.5.8. CELLTRION INC.
      • 9.5.8.1. Participant's Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Recent Developments
    • 9.5.9. Merck & Co., Inc.
      • 9.5.9.1. Participant's Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Recent Developments
    • 9.5.10. Johnson & Johnson Services, Inc
      • 9.5.10.1. Participant's Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Inflammatory Bowel Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 7 Global Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 Global Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 North America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 North America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 13 North America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 U.S. Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 16 U.S. Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 U.S. Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 Canada Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 20 Canada Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Canada Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 Europe Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 23 Europe Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Europe Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 Europe Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 26 Europe Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 29 Germany Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Germany Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 UK Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 UK Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 UK Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 UK Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 France Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 France Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 37 France Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 France Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Italy Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 Italy Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Italy Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Italy Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Spain Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Spain Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Spain Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Spain Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Denmark Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Denmark Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Denmark Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Sweden Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Sweden Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 Sweden Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 Norway Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 Norway Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 Norway Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 Norway Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Japan Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Japan Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66 Japan Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 Japan Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 China Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 China Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 China Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 China Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 India Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 India Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 74 India Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 India Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 South Korea Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 South Korea Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 78 South Korea Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 South Korea Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Australia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 81 Australia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 82 Australia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 83 Australia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 Singapore Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 85 Singapore Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 86 Singapore Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 Singapore Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 Thailand Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Thailand Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Thailand Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 Thailand Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Latin America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 93 Latin America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 Latin America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Latin America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Latin America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 97 Mexico Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 99 Mexico Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 100 Mexico Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 101 Brazil Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 102 Brazil Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 103 Brazil Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 104 Brazil Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 105 Argentina Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 Argentina Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 107 Argentina Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 Argentina Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 110 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 111 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 112 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 113 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 114 South Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 115 South Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 116 South Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 117 South Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 122 UAE Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 123 UAE Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 124 UAE Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 125 UAE Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 126 Kuwait Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 127 Kuwait Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 128 Kuwait Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 129 Kuwait Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Inflammatory bowel disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Inflammatory bowel disease treatment market: Type movement analysis
  • Fig. 17 Inflammatory bowel disease treatment market: Type segment dashboard
  • Fig. 18 Inflammatory bowel disease treatment market Type outlook: Key takeaways
  • Fig. 19 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Ulcerative Colitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Inflammatory bowel disease treatment market: Drug class movement analysis
  • Fig. 22 Inflammatory bowel disease treatment market: Drug class segment dashboard
  • Fig. 23 Inflammatory bowel disease treatment market Drug class outlook: Key takeaways
  • Fig. 24 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Inflammatory bowel disease treatment market: Route of administration movement analysis
  • Fig. 32 Inflammatory bowel disease treatment market: Route of administration segment dashboard
  • Fig. 33 Inflammatory bowel disease treatment market Route of administration outlook: Key takeaways
  • Fig. 34 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Inflammatory bowel disease treatment market: Distribution channel movement analysis
  • Fig. 37 Inflammatory bowel disease treatment market: Distribution channel segment dashboard
  • Fig. 38 Inflammatory bowel disease treatment market Distribution channel outlook: Key takeaways
  • Fig. 39 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2023 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 Europe, SWOT
  • Fig. 47 Asia Pacific, SWOT
  • Fig. 48 Latin America, SWOT
  • Fig. 49 Middle East and Africa, SWOT
  • Fig. 50 North America
  • Fig. 51 North America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S.
  • Fig. 53 U.S. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Canada
  • Fig. 55 Canada inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 Europe
  • Fig. 57 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 UK
  • Fig. 59 UK inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 Germany
  • Fig. 61 Germany inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 62 Spain
  • Fig. 63 Spain inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 France
  • Fig. 65 France inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Italy
  • Fig. 67 Italy inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Denmark
  • Fig. 69 Denmark inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 Norway
  • Fig. 71 Norway inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 Sweden
  • Fig. 73 Sweden inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific
  • Fig. 75 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan
  • Fig. 77 Japan inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 China
  • Fig. 79 China inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 80 India
  • Fig. 81 India inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea
  • Fig. 83 South Korea inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 84 Australia
  • Fig. 85 Australia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 86 Singapore
  • Fig. 87 Singapore inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand
  • Fig. 89 Thailand inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America
  • Fig. 91 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 92 Brazil
  • Fig. 93 Brazil inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 94 Mexico
  • Fig. 95 Mexico inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 96 Argentina
  • Fig. 97 Argentina inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 98 Middle East and Africa
  • Fig. 99 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 100 South Africa
  • Fig. 101 South Africa inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 102 Saudi Arabia
  • Fig. 103 Saudi Arabia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 104 UAE
  • Fig. 105 UAE inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 106 Kuwait
  • Fig. 107 Kuwait inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 108 Ansoff Matrix
  • Fig. 109 Heat map analysis
  • Fig. 110 Market differentiators